Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001567619-20-011158
Filing Date
2020-05-26
Accepted
2020-05-26 17:06:53
Documents
1
Effectiveness Date
2020-05-26
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6806
  Complete submission text file 0001567619-20-011158.txt   7831
Mailing Address 2500-10220 103 AVE NW EDMONTON A0 T5J 0K4
Business Address 2500-10220 103 AVE NW EDMONTON A0 T5J 0K4 780-862-7445
Entos Pharmaceuticals Inc. (Filer) CIK: 0001812824 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-367695 | Film No.: 20911621